Creating a Global Company

Creating a Global Company SUN PHARMA DUSA a SUN PHARMA company MERCK Agreement with +Biosintez InSite Vision Solutions for Sight Began with 5 products Acquired Dusa Merck for in- licensing Tildrakizumab Acquired InSite Vision ophthalmic portfolio. a SUN PHARMA company Acquired Biosintez in Russia POLA PHARMA Acquired Pola Pharma in Japan In-lincesed WinleviⓇ (clascoterone cream 1%) for acne treatment in US & Canada Year 1983 1994 2010 2012 2013 2014 2015 2016 2018 2019 2020 2021 2022 IPO Rs. 550 Mn raised RANBAXY URL PHARMA LABORATORIES LIMITED TARO Acquired Taro Acquired URL Pharma Acquired Ranbaxy Sun Pharma Today Entry into Japan Launch of Specialty products -Acquired 14 • Ilumya brands from • Cequa Novartis • Odomzo • Acquired Global • Absorica LD rights for • Yonsa Cequa & Xelpros Odomzo . Sprinkle products 37,000+ Global Employee Base Invested Rs. 209 Bn in R&D till date (Since 1994) BSE SENSEX NIFTY Stock of the nation Part of NSE Nifty & BSE Sensex in India 43 Manufacturing facilities in 6 Continents 67% of sales from international markets 15

View entire presentation